Andere talen Aarti Drugs Limited NSE India S.E.

Aandelen

AARTIDRUGS

INE767A01016

Vertraagde tijd NSE India S.E. Andere beurzen 08:00:07 17-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
485,6 ^INR	+0,10%		+5,32%	-0,60%

06/05	Transcript : Aarti Drugs Limited, Q4 2024 Earnings Call, May 06, 2024
03/05	Aarti Drugs Limited rapporteert resultaten voor het vierde kwartaal eindigend op 31 maart 2024	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Aarti Drugs Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	03/05
Aarti Drugs Limited Reports Earnings Results for the Full Year Ended March 31, 2024	03/05
Aarti Drugs Limited Announces Executive Cessation	29/03
Aarti Drugs Begins Manufacturing Dermatology Products in Tarapur, India Facility	31/01
Aarti Drugs Limited Initiates Commercial Production of Dermatology Product At New Facility in Tarapur, Maharashtra	30/01
Aarti Drugs Limited Announces Interim Dividend for the Financial Year 2023- 24	24/01
Aarti Drugs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	24/01
Aarti Drugs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	19-10-23
Tranche Update on Aarti Drugs Limited's Equity Buyback Plan announced on July 21, 2023.	28-08-23
Aarti Drugs Limited's Equity Buyback announced on July 21, 2023, has closed with 665,000 shares, representing 0.72% for INR 598.5 million.	17-08-23
Aarti Drugs Clocks Gains in Fiscal Q1 Consolidated Profit	24-07-23
Aarti Drugs Limited announces an Equity Buyback for 665,000 shares, representing 0.72% for INR 598.5 million.	21-07-23
Aarti Drugs Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	21-07-23
Aarti Drugs Limited authorizes a Buyback Plan.	21-07-23
Aarti Drugs Limited's Board intends to launch an Equity Buyback on July 21, 2023.	14-07-23
Aarti Drugs Limited's Board intends to launch an Equity Buyback on July 21, 2023.	14-07-23
Aarti Drugs' Consolidated Profit Climbs in Fiscal Q4	01-05-23
Aarti Drugs Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	29-04-23
Aarti Drugs' Consolidated Net Profit Declines in Fiscal Q3	30-01-23
Aarti Drugs Limited Declares Interim Dividend for the Financial Year 2022-23	27-01-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Aarti Drugs Limited NSE India S.E.

Aandelen

AARTIDRUGS

INE767A01016

Andere talen

Filters